FOXO TECHNOLOGIES INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
FOXO TECHNOLOGIES INC. (FOXO) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 128.97 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 303.16B shares, a 2319301.52% increase year-over-year.
- FOXO TECHNOLOGIES INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 13.07M shares, a 5628.21% increase year-over-year.
- FOXO TECHNOLOGIES INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 228.18K shares, a 84.33% decline year-over-year.
- FOXO TECHNOLOGIES INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 1.46M shares.
- FOXO TECHNOLOGIES INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 297.17B shares, a 5218026.21% increase from fiscal 2024.
- FOXO TECHNOLOGIES INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 5.69M shares, a 78.48% increase from fiscal 2023.
- FOXO TECHNOLOGIES INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 3.19M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 128.97K shares 10-Q · filed 2026-08-14 | ||||||||
| 2026-03-31 | 303.16B shares 10-Q · filed 2026-05-15 | ||||||||
| 2025-12-31 | 297.17B shares 10-K · filed 2026-04-15 | ||||||||
| 2025-09-30 | 6.30B shares 10-Q · filed 2025-11-10 | ||||||||
| 2025-06-30 | 26.35K shares 10-Q · filed 2026-08-14 | 79.02M shares 10-Q · filed 2025-08-19 | |||||||
| 2025-03-31 | 13.07M shares 10-Q · filed 2026-05-15 | 26.01M shares 10-Q · filed 2025-05-20 | |||||||
| 2024-12-31 | 5.69M shares 10-K · filed 2026-04-15 | 113.33M shares 10-K · filed 2025-04-15 | |||||||
| 2024-09-30 | 463.06K shares 10-Q · filed 2025-11-10 | 5.87B shares 10-Q · filed 2024-11-19 | |||||||
| 2024-06-30 | 431.40K shares 10-Q · filed 2025-08-19 | 5.79B shares 10-Q · filed 2024-08-19 | |||||||
| 2024-03-31 | 228.18K shares 10-Q/A · filed 2025-08-19 | 4.54M shares 10-Q · filed 2024-06-28 | |||||||
| 2023-12-31 | 3.19M shares 10-K · filed 2025-04-15 | ||||||||
| 2023-09-30 | 3.26M shares 10-Q/A · filed 2024-06-04 | 3.26B shares 10-Q · filed 2024-11-19 | |||||||
| 2023-06-30 | 1.29B shares 10-Q · filed 2024-08-19 | ||||||||
| 2023-03-31 | 1.46M shares 10-Q · filed 2024-06-28 | ||||||||
| 2022-09-30 | 1.53M shares 10-Q/A · filed 2024-06-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |